ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2178 • 2013 ACR/ARHP Annual Meeting

    Juvenile Onset Systemic Sclerosis: Clinical and Serological Features, and Mortality In Comparison With Adult Onset Disease

    Juan G. Ovalles-Bonilla1, Francisco Javier López-Longo2, Indalecio Monteagudo1, Esperanza Naredo1, Carlos Gonzalez Fernandez1, María Montoro Alvarez1, Lina Martínez-Estupiñán1, Juan C. Nieto3, Julia Martínez-Barrio1, Michelle Hinojosa1, Natalia Bello1, Belen Serrano1, Carmen Mata1 and Luis Carreño1, 1Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Hospital General Universitario Gregorio Marañón, Department of Rheumatology, Madrid, Spain, 3Hospital General Universitario Gregorio Marañón, Madrid, Spain

    Background/Purpose: Currently data regarding long-term outcome of juvenile systemic sclerosis (jSSc) is scarce. To describe the differences between patients with jSSc versus adult onset evaluated at a single medical…
  • Abstract Number: 2179 • 2013 ACR/ARHP Annual Meeting

    Consensus: What Agent To Use When First-Line Vasodilatadors Fail In Raynaud´s Phenomenon Or Digital Ulcers Secondary To Juvenile Systemic Sclerosis?

    Marìa M. Katsicas1, Mariana Gonzalez2 and Ricardo A. G. Russo3, 1Immunology & Rheumatology., Hospital de Pediatrìa Garrahan, Buenos Aires, Argentina, 2Immunology & Rheumatology, Hospital de Pediatría Garrahan, Buenos Aires, Argentina, 3Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina

    Background/Purpose: Juvenile Systemic Sclerosis (JSS) is characterized by Raynaud`s phenomenon (RP) and digital ulcers (DU).Conventional therapy includes calcium channel blockers (CCB). A growing number of…
  • Abstract Number: 2180 • 2013 ACR/ARHP Annual Meeting

    Presentation, Diagnosis, and Treatment Of Chronic Recurrent Multifocal Osteomyelitis

    Colin Anderson1, Erin Wylie2, Travis Heare3, Jamie Stewart4, Kelley Capocelli5, Shelley Dell'Orfano3 and Jennifer Soep6, 1Orthopaedic Surgery, The University of Colorado, Aurora, CO, 2Musculoskeletal Research Center, Children’s Hospital Colorado, Aurora, CO, 3Orthopaedic Surgery, Children’s Hospital Colorado, Aurora, CO, 4Pediatric Radiology, Children’s Hospital Colorado, Aurora, CO, 5Pediatric Pathology, Children’s Hospital Colorado, Aurora, CO, 6Pediatric Rheumatology, Children’s Hospital Colorado, Aurora, CO

    Background/Purpose: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare, non-infectious inflammatory bone disorder in children. Knowledge about the disorder is limited secondary to its rare…
  • Abstract Number: 2181 • 2013 ACR/ARHP Annual Meeting

    Methotrexate and Infliximab With Or Without Zoledronic Acid Improve Disease Activity and Prevent Damage Progression In Chronic Nonbacterial Osteomyelitis

    Yongdong (Dan) Zhao1, Nancy Chauvin2, Diego Jaramillo2 and Jon Burnham3, 1Rheumatology, Children's Hospital of Philadelphia, PHILADELPHIA, PA, 2Radiology, Children's Hospital of Philadelphia, PHILADELPHIA, PA, 3Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an inflammatory bone disease that causes pain, disability, and sometimes permanent skeletal damage. MRI allows for visualization of bone…
  • Abstract Number: 2182 • 2013 ACR/ARHP Annual Meeting

    Spectrum Of Musculoskeletal Inpatient Diagnoses At The Largest Pediatric Center In East Africa In 2011

    Angela Migowa1, Ines Colmegna2, Evelyne Ng'ang'a3, John Wachira4, Thomas Ngwiri5, Carol A. Hitchon6, Sasha Bernatsky7 and Rosie Scuccimarri8, 1Pediatrics, Aga Khan University Hospital, Nairobi, Kenya, 2Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 3Pediatrics, University of Nairobi, Nairobi, Kenya, 4Pediatrics, Gertrude's Children Hospital, Nairobi, Kenya, 5Pediatrics, Gertrude's Children's Hospital, Nairobi, Kenya, 6Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 7Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, 8McGill University, Montreal, QC, Canada

    Background/Purpose: Pediatric rheumatic diseases are among the most common chronic illnesses of childhood and can cause considerable disease burden and disability. The frequency and outcomes…
  • Abstract Number: 2183 • 2013 ACR/ARHP Annual Meeting

    Spectrum Of Outpatient Musculoskeletal Visits At The Largest Pediatric Center In East Africa In 2011

    Laurel Broten1, Angela Migowa2, Rosie Scuccimarri3, Evelyne Ng'ang'a4, John Wachira5, Thomas Ngwiri6, Sasha Bernatsky7, Carol A. Hitchon8 and Ines Colmegna9, 1Rheumatology, McGill University, Montreal, QC, Canada, 2Pediatrics, Aga Khan University Hospital, Nairobi, Kenya, 3McGill University, Montreal, QC, Canada, 4Pediatrics, University of Nairobi, Nairobi, Kenya, 5Pediatrics, Gertrude's Children Hospital, Nairobi, Kenya, 6Pediatrics, Gertrude's Children's Hospital, Nairobi, Kenya, 7Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, 8Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 9Rheumatology, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Pediatric rheumatic diseases are a major cause of morbidity, frequently leading to permanent disability, impaired functional status and quality of life, and significant direct…
  • Abstract Number: 2184 • 2013 ACR/ARHP Annual Meeting

    Application Of The Bonexpert Method For Bone Age and Bone Health Assessment In Patients With Juvenile Idiopathic Arthritis

    Charlotte M. Nusman1, Janneke Anink2, Lisette W.A. van Suijlekom-Smit2, Marion A.J. van Rossum3, Mario Maas4 and Rick R. van Rijn4, 1Department of Radiology, Academic Medical Center, Amsterdam, Netherlands, 2Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, 3Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center and Reade Institute, Amsterdam, Netherlands, 4Radiology, Academic Medical Center, Amsterdam, Netherlands

    Background/Purpose: Both the maturation of bone and its mineral density are affected by chronic inflammation in juvenile idiopathic arthritis (JIA). Bone age is in most…
  • Abstract Number: 2185 • 2013 ACR/ARHP Annual Meeting

    Three Middle Finger Width Correlates With Maximum Mouth Opening and Is a New Reliable Parameter To Identify Joint Hypermobility In Schoolchildren

    Francesca Sperotto1, Gabriella La Falce2, Fabio Vittadello1, Lorenzo Favero2 and Francesco Zulian3, 1Department of Pediatrics, University of Padua, Padua, Italy, 2Gnatology Unit, Department of Dentistry, Padua, Italy, 3PRINTO, Genoa, Italy

    Background/Purpose: Maximum mouth opening (MMO) is a useful parameter to identify common temporomandibular joint (TMJ) disorders. Up to now, a few studies addressed the issue…
  • Abstract Number: 2186 • 2013 ACR/ARHP Annual Meeting

    Lower Extremity Strength Is Related To Diminished Quality Of Life In Obese Children

    Sharon M. Bout-Tabaku1,2, Matt Briggs3, Tom Best2, Colleen Spees2, Ajit Chaudhari2 and Laura Schmitt4, 1Rheumatology, Nationwide Children's Hospital, Columbus, OH, 2The Ohio State University, Columbus, OH, 3School of Health and Rehabilitation Sciences, Division of Physical Therapy, The Ohio State University, Columbus, OH, 4Health and Rehabilitation Science, The Ohio State Universtiy, Columbus, OH

    Background/Purpose: Obese children have a higher prevalence of lower extremity (LE) pain, with associated diminished quality of life, greater knee malalignment, generate less knee extensor…
  • Abstract Number: 2187 • 2013 ACR/ARHP Annual Meeting

    Inter-Rater Reliability Of Jumping Mechanography In Healthy Children and Adults

    Johannes Roth1, Ciaran M. Duffy2, Tania Bennett1, Marta Erlandson3, Michele Gibbon4, Heather Macdonald5, Douglas Race6, Leanne M. Ward1 and Lori B. Tucker7, 1University of Ottawa, Ottawa, ON, Canada, 2Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5The University of British Columbia, Vancouver, BC, Canada, 6University of British Columbia, Vancouver, BC, Canada, 7Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Muscle function can be affected by many chronic disorders of childhood including Juvenile Idiopathic Arthritis (JIA). Whereas the term “muscle strength” is often used…
  • Abstract Number: 2188 • 2013 ACR/ARHP Annual Meeting

    Role of Interleukin-1 in Abnormal Monocyte Phenotype in Systemic Onset Juvenile Idiopathic Arthritis

    Yujuan Zhang1,2, Claudia Macaubas2, Clarissa Klein3, M. Virginia Pascual4, Arielle Hay5, Susan D. Thompson6, Christy I. Sandborg3, Norman T. Ilowite7 and Elizabeth D. Mellins8, 1Pediatrics, Stanford University Med Ctr, Palo Alto, CA, 2Pediatric Rheumatology, Stanford University Med Ctr, Stanford, CA, 3Stanford University Med Ctr, Stanford, CA, 4Baylor Institue for Immunology Research, Dallas, TX, 5The Children's Hospital at Montefiore, Bronx, NY, 6Department of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Pediatrics, The Children's Hospital at Montefiore, Bronx, NY, 8Dept of Pediatrics CCSR, Stanford University Medical Center, Stanford, CA

    Background/Purpose: Monocytes undergo phenotype changes when exposed to different microenvironments: the classic proinflammatory M1 phenotype, alternative regulatory M2 phenotype and M2-like phenotype, are each regulated…
  • Abstract Number: 2189 • 2013 ACR/ARHP Annual Meeting

    TLR 4 Endogenous Ligand MRP8/14 Levels in Enthesitis Related Arthritis (ERA) and Its Association With Disease Activity and TLR 4 Expression

    Amita Aggarwal1, Mujeeb Rahman1, Arpita Myles2, Priyanka Gaur2 and Ramnath Misra1, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Enthesitis related arthritis (ERA) is an inflammatory disease of childhood that lacks autoreactive T and B cells. We have previously shown that surface expressed…
  • Abstract Number: 2160 • 2013 ACR/ARHP Annual Meeting

    The Journey to Diagnosis in As/Axial Spondyloarthritis – the Psychological Impact of Delay

    Jane Martindale1,2 and Lynne Goodacre2, 1Physiotherapy, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom, 2Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom

    Background/Purpose: It is not uncommon for 8 to 11 years to pass between symptoms onset and definitive diagnosis of AS/axial SpA (Gran 1997, Feldtkeller, 2003).…
  • Abstract Number: 2150 • 2013 ACR/ARHP Annual Meeting

    Comparative Effectiveness Of Pharmacological Interventions For Knee Osteoarthritis: A Network Meta-Analysis

    Raveendhara R. Bannuru1, Timothy E. McAlindon2, John B. Wong3, David Kent4 and Christopher Schmid5, 1Rheumatology, Tufts Medical Center, Boston, MA, 2Division of Rheumatology, Tufts Medical Center, Boston, MA, 3Medicine/Clinical Decision Making, Tufts Medical Center, Boston, MA, 4Medicine, Tufts Medical Center, Boston, MA, 5Evidence-Based Practice Center, Brown University, Providence, RI

    Background/Purpose: With the rapidly aging US population and obesity epidemic, the prevalence of knee osteoarthritis (OA) is increasing exponentially. Although a wide variety of symptomatic…
  • Abstract Number: 2151 • 2013 ACR/ARHP Annual Meeting

    Synergistic Effect of Combining BioniCare® in an Unloading Brace for Osteoarthritis of the Knee

    Thomas Zizic1, David S. Hungerford2, Edmund J. MacLaughlin3, Craig Mines4, Shaili Deveshwar5, Theresa Lawrence Ford6, Cynthia Elliott6, John R. Principe7, Jack S. Tuber8 and Joy Schechtman9, 1Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Ortho Surgery, Johns Hopkins University, Baltimore, MD, 3The Johns Hopkins University School of Medicine, Cambridge, MD, 4East Side OrthoCare, Snellville, GA, 5Sports Medicine and Orthopedic Center, Greensboro, NC, 6North Georgia Rheumatology, Lawrenceville, GA, 7WellBeingMD, Palos Heights, IL, 8The Johns Hopkins University, Baltimore, Maryland, Baltimore, MD, 9SunValley Arthritis Center, Peoria, AZ

    Background/Purpose: The purpose of this study was to see if incorporating the BioniCare device into an unloading brace would produce more rapid improvement, greater compliance…
  • « Previous Page
  • 1
  • …
  • 2286
  • 2287
  • 2288
  • 2289
  • 2290
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology